• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Behind Every Successful eCOA Solution is a Robust Scientific Strategy
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Qosina

    CMC Pharmaceuticals

    IDT Biologika

    Aphena Pharma Solutions

    Biosynth Carbosynth
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Qosina

    CMC Pharmaceuticals

    IDT Biologika

    Aphena Pharma Solutions

    Biosynth Carbosynth
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion

    Efficient processing and production technology for solid molecular dispersion, HME can provide sustained, modified and targeted drug delivery.

    Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion
    Related CONTENT
    • Vio Chemicals
    • Sensum
    • Aenova
    • ViscoTec America Inc.
    • Ackley Machine Corporation
    Ameya Deshpande, Formulation Scientist, Avomeen05.25.21
    The therapeutic value of active pharmaceutical ingredients (APIs) in dosage forms such as tablets is limited by their aqueous solubility, limiting the insoluble APIs bioavailability to the cells and tissues where they’re needed most. This challenge is especially pertinent to drugs that are present in a crystalline state: While the ordered lattice structure improves the compound’s physical and chemical stability, crystalline drugs may have trouble dissolving in aqueous dissolution solutions and may not be fully absorbed.
     
    To compensate for the limited bioavailability of hydrophobic APIs, manufacturers may find it necessary to include a higher concentration in the batch to deliver the desired dose. This, in turn, may pose health risks to production personnel, especially if the drug is highly potent. It may also increase the cost of medication for patients and expose them to a greater risk of adverse effect. Finally, high API concentrations can make oral medications taste unpleasant, which can reduce treatment compliance.
     
    To overcome these challenges, the pharmaceutical industry has developed a technique called hot melt extrusion (HME). HME transforms the API into an amorphous form that is more soluble, thus increasing the bioavailability of the drug. This approach also forms a solid dispersion or solution composed of the API and solubility-enhancing excipients, preventing recrystallization in the long term to produce a more stable formulation. These molecular mixtures enable the manufacture of sustained, modified, time-controlled and targeted drug delivery with optimal efficacy. Additionally, the polymers used to form these structures mask the undesirable taste of the API.
     
    HME is commonly used for formulating oral dosage forms such as tablets, soft gelatin capsules, and thin films, but they can also be used for subcutaneous and intraocular implants, intravaginal rings, and stick packs. HME is a viable technology for both high dose and potent compounds. The best candidate drug substances are those that are thermostable and exhibit poor solubility characteristics; however, the short processing time involved in HME does allow for the use of some less stable compounds as well.
     
    How Hot Melt Extrusion Works
     
    The HME technique involves pumping the API and other excipients, such as a binder and polymers, through a heated barrel at a controlled temperature. The manufacturer embeds functional excipients and the API in a carrier formulation that melts during the extrusion process, converting these components into an amorphous dispersion with a uniform shape and density. This product ultimately increases the dissolution rate, and therefore the bioavailability, of the API.
     
    Though manufacturers use most of the same raw materials for HME as they do for other solid dosage forms, the nature of HME protocol limits the set of individual components that can be used to those that are thermally stable. Manufactures must be highly selective in their choice of materials since different functional excipients and complex APIs can drastically impact the success of the process and the final drug formulation. The high temperatures associated with HME processing destabilize the APIs, so the API should be monitored for thermal and oxidative drug degradation throughout the manufacturing process. Specifically, manufacturers must use stability-indicating analytical methods that will assure the identity, strength. quality and purity of the hot melt extruded pharmaceutical formulations.
     
    The Advantages of Hot Melt Extrusion

     
    HME offers several advantages over traditional processing techniques. For example, it doesn’t use costly and hazardous solvents, it involves fewer processing steps, and it can be operated continuously to save time. Overall, HME produces a purer, more efficient process and a more effective product.
     
    Additionally, one of the unique benefits of HME is its ability to mask the bitter taste of certain APIs by embedding the API within the matrix of a polymer. Stronger drug-polymer interactions increase this taste masking effect, further demonstrating the importance of ensuring that the excipients used are compatible with the API.
     
    The technique also offers some specific benefits to manufacturers who are working with highly potent drugs that can pose risks to pharmaceutical processing personnel as well as the intended patient population. The entire HME workflow is contained and controlled, reducing the pharmaceutical processing personnel’s exposure to the API and drug product. HME also produces a consistent and accurate low-dose product that can reliably deliver the desired therapeutic effect, reducing patients’ risks of dosing errors and side effects, thus increasing patient compliance with the treatment regimen and improving patient outcomes.
     
    For a team of knowledgeable formulation scientists that is tasked with developing drug delivery systems and working with formulations that are thermally stable, HME is an efficient processing and production technology for solid molecular dispersion. HME can provide sustained, modified and targeted drug delivery with improved stability and bioavailability. This technique will help manufacturers save money by increasing production efficiency and reducing waste and may offer pharmaceutical manufactures, and ultimately the intended patients, access to equally effective drug products at significantly lower prices.


    Ameya Deshpande, M.S., is a Formulation Scientist at Avomeen. Avomeen’s clients benefit greatly from Ameya’s experience in pharmaceutical formulation development and his extensive knowledge of novel drug delivery systems including hot melt extrusion. His proficiency in formulation development includes the utilization of a Quality by Design (QBD) approach to develop drug products for Investigational New Drug (IND) Application and Abbreviated New Drug Application (ANDA). His expertise extends to pre-formulation testing including drug-excipient compatibility testing, physicochemical testing of drug substances and early stage drug product prototypes involving structural characterization, solubility profiling, determination of flow properties, wettability, rheological studies, impurity profiling and stability studies.
    Related Searches
    • Formulation Development
    Suggested For You
    Vio Chemicals Vio Chemicals
    Sensum Sensum
    Aenova Aenova
    ViscoTec America Inc. ViscoTec America Inc.
    Ackley Machine Corporation Ackley Machine Corporation
    Scout Scientific LLC Scout Scientific LLC
    Raman Spectroscopy for Pharmaceutical Analysis & Quality Control Raman Spectroscopy for Pharmaceutical Analysis & Quality Control
    Avomeen Appoints Formulation and Clinical Trial Mfg. Director Avomeen Appoints Formulation and Clinical Trial Mfg. Director
    AltheaDx Expands Commercial Leadership Team AltheaDx Expands Commercial Leadership Team
    Tablet Development Process Training - July 20-21 Tablet Development Process Training - July 20-21
    Argonaut Expands Lyophilization Facility Argonaut Expands Lyophilization Facility
    Resilience Bolsters Canadian Biomanufacturing Site Resilience Bolsters Canadian Biomanufacturing Site
    HPAPI Development and Manufacturing Trends HPAPI Development and Manufacturing Trends
    Pfizer, BioNTech to Supply EU with Additional COMIRNATY Doses Pfizer, BioNTech to Supply EU with Additional COMIRNATY Doses
    Arecor, Lilly Sign Formulation Study Partnership Arecor, Lilly Sign Formulation Study Partnership

    Related Buyers Guide Companies

    • Vio Chemicals

      ...
      Ioanna Kazantzidou, Marketing Communications Officer 12.07.21

    • Sensum

      ...
      Marko Sraj, BDM 12.06.21

    • Aenova

      Aenova

      ...
      Susanne Knabe, Head of Communication & PR 11.30.21


    • ViscoTec America Inc.

      ...
      Melanie Hintereder, Marketing 11.05.21

    • Ackley Machine Corporation

      ...
      Liv, Marketing Manager 11.03.21

    Loading, Please Wait..
    Trending
    • Almac Invests $65M To Expand North American HQ
    • Just – Evotec Biologics And Alpine Immune Sciences Expand Partnership
    • West Pharmaceutical Makes Strategic Investment In Latch Medical
    • AskBio Appoints Clinical Ops Executives
    • Catalent To Acquire Metrics Contract Services For $475M
    Breaking News
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    • Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership
    • Almac Invests $65M to Expand North American HQ
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Consumers are Clamoring for Vintage Glam: Spate
    Kayali’s Lovefest Fragrance, Newell’s New Candle and HydraFacial’s Record Financial Results
    Self Care Trumps Home Care Post-Covid
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login